PRMT5 and neuroblastoma: As our previous immunohistochemical analyses of primary tumours had demonstrated very high nuclear PRMT5 in poor prognosis MNA neuroblastoma, in contrast to predominantly cytoplasmic PRMT5 in other neuroblastomas [5], we focused on nuclear deregulatory events.